These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22120488)

  • 1. Dyslipidaemia among Nigerian oil workers with type 2 diabetes mellitus.
    Edo A; Adediran OS
    West Afr J Med; 2011; 30(3):206-9. PubMed ID: 22120488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipid profile of Nigerian diabetics with end stage renal disease.
    Agaba EI; Duguru M; Agaba PA; Angbazo D
    West Afr J Med; 2005; 24(4):305-8. PubMed ID: 16483045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.
    Ismail IS; Nazaimoon W; Mohamad W; Letchuman R; Singaraveloo M; Hew FL; Shuguna C; Khalid BA
    Diabet Med; 2001 Jun; 18(6):501-8. PubMed ID: 11472471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Serum Lipid Profile with Anthropometric and Clinical Variables in Patients with Type 2 Diabetes Mellitus.
    Biadgo B; Abebe SM; Baynes HW; Yesuf M; Alemu A; Abebe M
    Ethiop J Health Sci; 2017 May; 27(3):215-226. PubMed ID: 29217920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidaemia among black patients with type 2 diabetes.
    Vezi ZB; Naidoo DP
    Cardiovasc J S Afr; 2005; 16(4):194-8. PubMed ID: 16211122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of glycaemic control on the prevalence and pattern of dyslipidaemia in Nigerian patients with newly diagnosed non insulin dependent diabetes mellitus.
    Agboola-Abu CF; Ohwovoriole AE; Akinlade KS
    West Afr J Med; 2000; 19(1):27-33. PubMed ID: 10821083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of total cholesterol and high density lipoprotein--cholesterol ratio in interpreting lipid profile results of diabetes mellitus patients.
    Mshelia DS; Garbati MA; Ndahi AA; Mamza YP; Sheikh HA
    Niger J Clin Pract; 2009 Dec; 12(4):345-9. PubMed ID: 20329668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.
    Ogunro PS; Balogun WO; Fadero FF; Idogun ES; Oninla SO; Elemile PO; Eziyi AK
    West Afr J Med; 2009 Mar; 28(2):87-91. PubMed ID: 19761169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa.
    Pitso L; Mofokeng TRP; Nel R
    BMC Endocr Disord; 2021 Aug; 21(1):159. PubMed ID: 34365977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM; Giri R; Kameswara Rao B; Apparao C
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
    Bruckert E; Baccara-Dinet M; Eschwege E
    Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Diabetic Dyslipidemia.
    Hirano T
    J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria.
    Odenigbo CU; Oguejiofor OC; Odenigbo UM; Ibeh CC; Ajaero CN; Odike MA
    Niger J Clin Pract; 2008 Dec; 11(4):330-5. PubMed ID: 19320405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive lipid-lowering strategy in patients with diabetes mellitus.
    Kanters SD; Algra A; de Bruint TW; Erkelens DW; Banga JD
    Diabet Med; 1999 Jun; 16(6):500-8. PubMed ID: 10391399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.